Grim Age, Grim Prognosis
Grim EAA may serve as a preoperative risk assessment tool for patients with resectable PDAC, potentially guiding personalized treatment. Further validation is required for clinical integration.
Authors
- Martin Sillesen (ORCID: https://orcid.org/0000-0001-9494-5475)
- Jesper Frank Christensen (ORCID: https://orcid.org/0000-0003-4858-1505)
- Mikkel Bonde
- Paul Suno Krohn
- Astrid Z. Johansen (ORCID: https://orcid.org/0000-0002-4948-6799)
- Stefan Kobbelgaard Burgdorf (ORCID: https://orcid.org/0000-0003-2844-2129)
- Carsten Palnæs Hansen (ORCID: https://orcid.org/0000-0002-9256-2240)
- Julia S. Johansen (ORCID: https://orcid.org/0000-0002-4217-6560)
- Emilie Even Dencker
- Sophie Kollbeck (ORCID: https://orcid.org/0000-0002-2354-3679)
- Andreas Skov Millarch
- Jens Hillingsø
- Jan Henrik Storkholm
Institutions
- University of Copenhagen (DK)
- Imperial College Healthcare NHS Trust (GB)
- Hammersmith Hospital (GB)
- Herlev Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1097/sla.0000000000006886
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00